Ascendis Pharma A (ASND) Invested Capital (2020 - 2025)

Ascendis Pharma A (ASND) has 6 years of Invested Capital data on file, last reported at $1.0 billion in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 10.86% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 10.86% YoY), and the FY2025 full-year result was $1.0 billion, up 9.45% from the prior year.
• Invested Capital climbed to $1.0 billion in Q4 2025, from $915.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.0 billion in Q4 2025 to a low of $120.1 million in Q4 2021.
• A 5-year average of $652.4 million and a median of $693.2 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital gained 9.49% in 2021 and jumped 331.96% in 2022, its largest moves.
• Tracing ASND's Invested Capital over 5 years: stood at $120.1 million in 2021, then jumped by 331.96% to $518.7 million in 2022, then surged by 33.65% to $693.2 million in 2023, then jumped by 32.05% to $915.4 million in 2024, then increased by 10.86% to $1.0 billion in 2025.
• Business Quant data shows ASND's Invested Capital at $1.0 billion in Q4 2025, $915.4 million in Q4 2024, and $693.2 million in Q4 2023.